Long-term use of etelcalcetide for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis for end-stage renal failure: a real-life retrospective observational study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,Nephrology
Link
https://link.springer.com/content/pdf/10.1007/s11255-023-03505-4.pdf
Reference33 articles.
1. Kestenbaum B, Belozeroff V (2007) Mineral metabolism disturbances in patients with chronic kidney disease. Eur J Clin Invest 37:607–622. https://doi.org/10.1111/j.1365-2362.2007.01840.x
2. Goodman WG (2004) The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease. Semin Dial 17:209–216. https://doi.org/10.1111/j.0894-0959.2004.17308.x
3. Rodriguez M, Canalejo A, Garfia B et al (2002) Pathogenesis of refractory secondary hyperparathyroidism. Kidney Int Suppl. https://doi.org/10.1046/j.1523-1755.61.s80.26.x
4. Cozzolino M, Olivi L, Voli E et al (2009) PREVENZIONE E TRATTAMENTO DELL’IPERPARATIROIDISMO SECONDARIO NEL PAZIENTE CON MALATTIA RENALE CRONICA ALLO STADIO NON IN DIALISI. G Ital Nefrol 26(S49):S30–S35
5. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. https://doi.org/10.1038/ki.2009.188
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3